Predictors of Gleason Score (GS) upgrading on subsequent prostatectomy: a single Institution study in a cohort of patients with GS 6
- PMID: 22949931
- PMCID: PMC3430101
Predictors of Gleason Score (GS) upgrading on subsequent prostatectomy: a single Institution study in a cohort of patients with GS 6
Abstract
Background: Biopsy Gleason score (bGS) remains an important prognostic indicator for adverse outcomes in Prostate Cancer (PCA). In the light of recent studies purporting difference in prognostic outcomes for the subgroups of GS7 group (primary Gleason pattern 4 vs. 3), upgrading of a bGS of 6 to a GS≥7 has serious implications. We sought to identify pre-operative factors associated with upgrading in a cohort of GS6 patients who underwent prostatectomy.
Design: We identified 281 cases of GS6 PCA on biopsy with subsequent prostatectomies. Using data on pre-operative variables (age, PSA, biopsy pathology parameters), logistic regression models (LRM) were developed to identify factors that could be used to predict upgrading to GS≥7 on subsequent prostatectomy. A decision tree (DT) was constructed.
Results: 92 of 281 cases (32.7%) were upgraded on subsequent prostatectomy. LRM identified a model with two variables with statistically significant ability to predict upgrading, including pre-biopsy PSA (Odds Ratio 8.66; 2.03-37.49, 95% CI) and highest percentage of cancer at any single biopsy site (Odds Ratio 1.03, 1.01-1.05, 95% CI). This two-parameter model yielded an area under curve of 0.67. The decision tree was constructed using only 3 leave nodes; with a test set classification accuracy of 70%.
Conclusions: A simplistic model using clinical and biopsy data is able to predict the likelihood of upgrading of GS with an acceptable level of certainty. External validation of these findings along with development of a nomogram will aid in better stratifying the cohort of low risk patients as based on the GS.
Keywords: Carcinoma; binary recursive partitioning; prostate/pathology/predictive modeling; statistical techniques/logistic regression.
Figures

Similar articles
-
Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series.Urol Oncol. 2011 Sep-Oct;29(5):508-14. doi: 10.1016/j.urolonc.2009.07.003. Epub 2009 Oct 17. Urol Oncol. 2011. PMID: 19837614 Clinical Trial.
-
Prostate-specific antigen 10-20 ng/mL: A predictor of degree of upgrading to ≥8 among patients with biopsy Gleason score 6.Investig Clin Urol. 2017 Mar;58(2):90-97. doi: 10.4111/icu.2017.58.2.90. Epub 2017 Feb 15. Investig Clin Urol. 2017. PMID: 28261677 Free PMC article.
-
[Clinically predictive factors of Gleason score upgrading in patients after radical prostatectomy].Beijing Da Xue Xue Bao Yi Xue Ban. 2016 Aug 18;48(4):603-606. Beijing Da Xue Xue Bao Yi Xue Ban. 2016. PMID: 29263497 Chinese.
-
Prostate Volume is A Predictor of Gleason Score Upgrading after Radical Prostatectomy in Low-Risk Prostate Cancer: A Systematic Review and Meta-analysis.Urol J. 2024 Feb 28;21(1):20-28. doi: 10.22037/uj.v20i.7796. Urol J. 2024. PMID: 38087971
-
Men with High Prostate Specific Antigen Have Higher Risk of Gleason Upgrading after Prostatectomy: A Systematic Review and Meta-analysis.Urol J. 2020 Oct 21;18(5):477-484. doi: 10.22037/uj.v16i7.6127. Urol J. 2020. PMID: 33084002
Cited by
-
Determinants of Mortality among Patients Managed for Prostate Cancer: Experience from Korle Bu Teaching Hospital in Ghana.J West Afr Coll Surg. 2023 Jul-Sep;13(3):65-70. doi: 10.4103/jwas.jwas_26_23. Epub 2023 Jun 27. J West Afr Coll Surg. 2023. PMID: 37538217 Free PMC article.
-
Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy.Diagnostics (Basel). 2020 Dec 23;11(1):10. doi: 10.3390/diagnostics11010010. Diagnostics (Basel). 2020. PMID: 33374618 Free PMC article.
-
Risk factors for Gleason score upgrade from prostate biopsy to radical prostatectomy.Explor Target Antitumor Ther. 2024;5(4):981-996. doi: 10.37349/etat.2024.00259. Epub 2024 Jul 30. Explor Target Antitumor Ther. 2024. PMID: 39280242 Free PMC article. Review.
-
Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature.BJU Int. 2014 Dec;114(6b):E120-E129. doi: 10.1111/bju.12771. Epub 2014 Aug 13. BJU Int. 2014. PMID: 24731026 Free PMC article.
-
Exploration on Gleason score variation trend of patients with prostate carcinoma from 1996 to 2019: a retrospective single center study.Gland Surg. 2021 Feb;10(2):607-617. doi: 10.21037/gs-20-659. Gland Surg. 2021. PMID: 33708544 Free PMC article.
References
-
- King CR, McNeal JE, Gill H, Presti JC Jr. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. International journal of radiation oncology, biology, physics. 2004;59:386–391. - PubMed
-
- King CR. Patterns of prostate cancer biopsy grading: trends and clinical implications. International journal of cancer. Journal international du cancer. 2000;90:305–311. - PubMed
-
- Cam K, Yucel S, Turkeri L, Akdas A. Accuracy of transrectal ultrasound guided prostate biopsy: histopathological correlation to matched prostatectomy specimens. International journal of urology : official journal of the Japanese Urological Association. 2002;9:257–260. - PubMed
-
- King CR, Long JP. Prostate biopsy grading errors: a sampling problem? International journal of cancer. Journal international du cancer. 2000;90:326–330. - PubMed
-
- Mian BM, Lehr DJ, Moore CK, Fisher HA, Kaufman RP Jr, Ross JS, Jennings TA, Nazeer T. Role of prostate biopsy schemes in accurate prediction of Gleason scores. Urology. 2006;67:379–383. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous